PCRB vs. MYCI
PCRB (Putnam ESG Core Bond ETF -) and MYCI (State Street My2029 Corporate Bond ETF) are both exchange-traded funds - PCRB is a Intermediate Core Bond fund actively managed by Putnam, while MYCI is a Corporate Bonds fund actively managed by State Street. Both are actively managed. Their correlation of 0.84 suggests significant overlap in exposure. PCRB charges 0.35%/yr vs 0.15%/yr for MYCI.
Performance
PCRB vs. MYCI - Performance Comparison
Loading charts...
Returns By Period
PCRB
- 1D
- —
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MYCI
- 1D
- 0.22%
- 1M
- 0.03%
- 6M
- 0.66%
- YTD
- 0.68%
- 1Y
- 4.11%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PCRB vs. MYCI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
PCRB Putnam ESG Core Bond ETF - | -0.48% | 7.21% | -3.04% |
MYCI State Street My2029 Corporate Bond ETF | 0.68% | 7.59% | -1.58% |
Correlation
The correlation between PCRB and MYCI is 0.82, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.82 |
Correlation (All Time) Calculated using the full available price history since Sep 24, 2024 | 0.84 |
The correlation between PCRB and MYCI has been stable across timeframes, ranging from 0.82 to 0.84 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PCRB vs. MYCI — Risk / Return Rank
PCRB
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
MYCI
PCRB vs. MYCI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Putnam ESG Core Bond ETF - (PCRB) and State Street My2029 Corporate Bond ETF (MYCI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PCRB | MYCI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.37 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.64 | — |
| Martin ratioReturn relative to average drawdown | — | 9.40 | — |
Loading charts...
Drawdowns
PCRB vs. MYCI - Drawdown Comparison
Loading charts...
Drawdown Indicators
| PCRB | MYCI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -2.43% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -1.56% | — |
Current DrawdownCurrent decline from peak | — | -0.33% | — |
Average DrawdownAverage peak-to-trough decline | — | -0.53% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.44% | — |
Volatility
PCRB vs. MYCI - Volatility Comparison
Loading charts...
Volatility by Period
| PCRB | MYCI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.64% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 1.64% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 2.13% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 2.99% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 2.99% | — |
PCRB vs. MYCI - Expense Ratio Comparison
PCRB has a 0.35% expense ratio, which is higher than MYCI's 0.15% expense ratio.
Dividends
PCRB vs. MYCI - Dividend Comparison
PCRB has not paid dividends to shareholders, while MYCI's dividend yield for the trailing twelve months is around 4.56%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
MYCI State Street My2029 Corporate Bond ETF | 4.56% | 4.56% | 1.19% | 0.00% |
PCRB Putnam ESG Core Bond ETF - | 9.42% | 4.30% | 4.38% | 3.65% |
Frequently Asked Questions
PCRB and MYCI have a correlation of 0.82, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, MYCI is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
MYCI is cheaper with a 0.15% expense ratio, compared with 0.35% for PCRB.
PCRB has the higher dividend yield at 9.42%, compared with 4.56% for MYCI.
PCRB is categorized as Intermediate Core Bond, while MYCI is Corporate Bonds. They also come from different issuers: Putnam and State Street. Their fees differ too: 0.35% for PCRB and 0.15% for MYCI.
Find the right allocation for PCRB and MYCI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer